TRABER PETER G

Average Profitability
22.8%
Insider Buys Quantity
11
Insider Buys Sum
$154,496.80
Insider Sells Quantity
2
Insider Sells Sum
$1.16M

Insider Activity of TRABER PETER G

The largest purchase of all time was on 2014-08-14 and amounted to 8000 shares of Galectin Therapeutics Inc. for $35,593.

The largest sale of all time was on 2018-06-13 and amounted to 100000 shares of Galectin Therapeutics Inc. for $751,000.

Biography of TRABER PETER G

No biography is available at this moment.

2018-06-13SaleGalectin Therapeutics Inc.
GALT
President & CEO
100,000
0.2512%
$7.51$751,000-38.11%
2018-06-08SaleGalectin Therapeutics Inc.
GALT
President & CEO
70,000
0.1738%
$5.86$409,997-20.99%
2015-08-12PurchaseGalectin Therapeutics Inc.
GALT
President & CEO
4,000
0.0141%
$2.00$8,000-34.87%
2015-06-01PurchaseGalectin Therapeutics Inc.
GALT
President & CEO
8,000
0.0317%
$2.53$20,240-30.11%
2014-08-14PurchaseGalectin Therapeutics Inc.
GALT
President and CEO
8,000
0.035%
$4.45$35,593-23.43%
2014-08-13PurchaseGalectin Therapeutics Inc.
GALT
President and CEO
2,000
0.0091%
$4.42$8,831-19.29%
2013-12-09PurchaseGalectin Therapeutics Inc.
GALT
President and CEO
1,000
0.0057%
$8.90$8,900+22.48%
2013-12-05PurchaseGalectin Therapeutics Inc.
GALT
President and CEO
1,000
0.0057%
$9.00$9,000+20.89%
2013-11-19PurchaseGalectin Therapeutics Inc.
GALT
President and CEO
2,000
0.0097%
$5.53$11,060+66.72%
2013-11-18PurchaseGalectin Therapeutics Inc.
GALT
President and CEO
2,000
0.0116%
$5.80$11,598+89.32%
2012-10-12PurchaseGalectin Therapeutics Inc.
GALT
President and CEO
5,000
0.0311%
$2.11$10,574+85.12%
2012-10-09PurchaseGalectin Therapeutics Inc.
GALT
President and CEO
5,000
0.0307%
$2.00$10,000+92.72%
2012-10-08PurchaseGalectin Therapeutics Inc.
GALT
President and CEO
10,000
0.0626%
$2.07$20,700+89.47%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.